180 Degree Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 107
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 54
Rounds per year 2.74
Lead investments 7
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 21
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Manufacturing
  • Biotechnology
  • Nanotechnology
  • Semiconductor
  • Electronics
Summary

180 Degree Capital is the famous VC, which was founded in 1983. The company was established in North America in United States. The main department of described VC is located in the New York.

Besides them, we counted 4 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the 180 Degree Capital, startups are often financed by DFJ, The Aurora Funds, VantagePoint Capital Partners. The meaningful sponsors for the fund in investment in the same round are VantagePoint Capital Partners, ATA Ventures, The Aurora Funds. In the next rounds fund is usually obtained by VantagePoint Capital Partners, Sevin Rosen Funds, In-Q-Tel.

Among the most popular portfolio startups of the fund, we may highlight BioVex, ORIG3N, Nanomix. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Software, Medical. The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The fund is generally included in 2-6 deals every year. Comparing to the other companies, this 180 Degree Capital performs on 11 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 14 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2011. The typical startup value when the investment from 180 Degree Capital is 10-50 millions dollars. The high activity for fund was in 2008.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of 180 Degree Capital:
Typical Co-investors
180 Degree Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after 180 Degree Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Magnolia NeuroSciences

Biotechnology
Health Care
Neuroscience
Wellness
$31M13 Aug 2018 New York, New York, United States

Biotechnology
Health Care
Medical
Personal Health
$14M12 Jul 2018 Boston, Massachusetts, United States

EchoPixel

Biotechnology
Health Care
Medical
$8M19 Oct 2017 California, United States

NGX Bio

Biotechnology
Genetics
Marketplace
Medical
Online Portals
$3M15 Aug 2017 New Jersey, United States

ORIG3N

Biotechnology
Health Care
Medical
Personal Health
$20M27 Jun 2017 Boston, Massachusetts, United States

Lodo Therapeutics

Biotechnology
Health Care
Pharmaceutical
$17M11 Jan 2016 New York, New York, United States

TARA Biosystems

Biotechnology
Medical
$2M08 Jan 2016 New York, New York, United States

Petra Pharma

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$48M06 Jan 2016 New York, United States

ORIG3N

Biotechnology
Health Care
Medical
Personal Health
$12M12 Dec 2015 Boston, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent 180 Degree Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: